Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORITAVANCIN vs ORPHENADRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ORITAVANCIN vs ORPHENADRINE: Safety Overview

Metric ORITAVANCIN ORPHENADRINE
Total FAERS Reports 884 584
Deaths Reported 29 121
Death Rate 3.3% 20.7%
Hospitalizations 157 159
Average Patient Age 55.9 yrs 47.9 yrs
% Female Patients 52.2% 79.3%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Melinta Therapeutics, LLC Sandoz Inc
Route INTRAVENOUS ORAL
Marketing Status N/A Discontinued